Literature DB >> 9651393

Topoisomerase IV catalysis and the mechanism of quinolone action.

V E Anderson1, T D Gootz, N Osheroff.   

Abstract

Topoisomerase IV is a bacterial type II topoisomerase that is essential for proper chromosome segregation and is a target for quinolone-based antimicrobial agents. Despite the importance of this enzyme to the survival of prokaryotic cells and to the treatment of bacterial infections, relatively little is known about the details of its catalytic mechanism or the basis by which quinolones alter its enzymatic functions. Therefore, a series of experiments that analyzed individual steps of the topoisomerase IV catalytic cycle were undertaken to address these critical mechanistic issues. The following conclusions were drawn. First, equilibrium levels of DNA cleavage mediated by the bacterial enzyme were considerably (>10-fold) higher than those observed with its eukaryotic counterparts. To a large extent, this reflected decreased rates of DNA religation. Second, the preference of topoisomerase IV for catalyzing DNA decatenation over relaxation reflects increased rates of strand passage and enzyme recycling rather than a heightened recognition of intermolecular DNA helices. Third, quinolones stimulate topoisomerase IV-mediated DNA cleavage both by increasing rates of DNA scission and by inhibiting religation of cleaved DNA. Finally, quinolones inhibit the overall catalytic activity of topoisomerase IV primarily by interfering with enzyme-ATP interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651393     DOI: 10.1074/jbc.273.28.17879

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Topoisomerase IV, alone, unknots DNA in E. coli.

Authors:  R W Deibler; S Rahmati; E L Zechiedrich
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

3.  Assessing sensitivity to antibacterial topoisomerase II inhibitors.

Authors:  Sonia K Morgan-Linnell; Hiroshi Hiasa; Lynn Zechiedrich; John L Nitiss
Journal:  Curr Protoc Pharmacol       Date:  2007-12

4.  Crystallization and X-ray diffraction data collection of topoisomerase IV ParE subunit from Xanthomonas oryzae pv. oryzae.

Authors:  Hye Jeong Shin; Mirim Yun; Ju Yeon Song; Hyun Jeong Kim; Yong Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-05-22

5.  Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV.

Authors:  Elizabeth G Gibson; Alexandria A Oviatt; Monica Cacho; Keir C Neuman; Pan F Chan; Neil Osheroff
Journal:  Biochemistry       Date:  2019-10-28       Impact factor: 3.162

6.  Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.

Authors:  Laura Casu; Filippo Cottiglia; Marco Leonti; Alessandro De Logu; Emanuela Agus; Yuk-Ching Tse-Dinh; Valentina Lombardo; Claudia Sissi
Journal:  Bioorg Med Chem Lett       Date:  2011-10-01       Impact factor: 2.823

7.  Crystallization and preliminary X-ray crystallographic analysis of DNA gyrase GyrB subunit from Xanthomonas oryzae pv. oryzae.

Authors:  Ha Yun Jung; Ki Jeung Lee; Kyung Ha Kim; Ji Hye Hyoung; Mi Ra Han; Hyun Kyoung Kim; Lin-Woo Kang; Yeh-Jin Ahn; Yong-Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

8.  Preliminary X-ray crystallographic analysis of the breakage-reunion domain of the GyrA subunit of DNA gyrase from Colwellia psychrerythraea strain 34H.

Authors:  Ha Yun Jung; Kyung Ha Kim; Ji Hye Hyoung; Mi Ra Han; Hyun Kyoung Kim; Ki Jeung Lee; Yangmee Kim; Hak Jun Kim; Yong Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-31

9.  Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.

Authors:  Sidharth Chopra; Karen Matsuyama; Tran Tran; Jeremiah P Malerich; Baojie Wan; Scott G Franzblau; Shichun Lun; Haidan Guo; Mariama C Maiga; William R Bishai; Peter B Madrid
Journal:  J Antimicrob Chemother       Date:  2011-11-02       Impact factor: 5.790

10.  Fluoroquinolones in the Treatment of Meningitis.

Authors:  Philippe Cottagnoud; Martin G. Täuber
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.